Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.160 Biomarker phenotype BEFREE PPARα agonists (fibrates) and PPARγ agonists (thiazolidinediones) are used for the treatment of hypertriglyceridemia and type 2 diabetes, respectively. 31825687 2020
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.160 GeneticVariation phenotype BEFREE Patients with LMNA (n = 22) or PPARG pathogenic variants (n = 7), leptin <12 ng/mL, and diabetes, insulin resistance, or high triglycerides. 31194872 2019
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.160 AlteredExpression phenotype BEFREE In relation to its effects on the hyperglycemia and hypertriglyceridemia, few is known about the mechanisms in which this compound may be acting, therefore, the aim of the present study was to determine if CGA acts as an insulin secretagogue increasing intracellular calcium concentrations ([Ca<sup>2+</sup>]<sub>i</sub>) in RINm5F cells; or as an insulin sensitizer and lipid-lowering agent stimulating the expression of PPARγ and PPARα, respectively, in 3T3-L1 adipocytes. 28759754 2017
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.160 GeneticVariation phenotype BEFREE For the C1431T polymorphism in PPARγ, while patients with the T allele (48.4%) had trends toward lower rate of hypertriglyceridemia, the borderline significance together with insignificant power did not support the protective effect of the T allele against development of hypertriglyceridemia. 23145084 2012
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.160 GeneticVariation phenotype BEFREE The most prevalent human PPARgamma gene variant, Ala12, is associated with postprandial hypertriglyceridemia in patients with metabolic syndrome, although the mechanism whereby this polymorphism affects lipid homeostasis remains to be fully determined. 18424599 2008
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.160 GeneticVariation phenotype BEFREE Pro12Ala sequence variant of the PPARG gene is associated with postprandial hypertriglyceridemia in non-E3/E3 patients with the metabolic syndrome. 16916989 2006